12 Health Care Stocks Moving In Monday's After-Market Session

周一盘后交易时段，12只医疗保健股走势

Benzinga · 2023/09/25 17:31

Femasys (NASDAQ:FEMY) shares moved upwards by 56.8% to $0.52 during Monday's after-market session. This security traded at a volume of 461.0K shares come close, making up 12.7% of its average volume over the last 100 days. The company's market cap stands at $7.8 million.
Pliant Therapeutics (NASDAQ:PLRX) stock rose 15.85% to $16.89. The company's market cap stands at $1.0 billion.
Ontrak (NASDAQ:OTRK) stock moved upwards by 10.45% to $0.95. The company's market cap stands at $4.6 million.
Brainstorm Cell (NASDAQ:BCLI) stock moved upwards by 9.42% to $0.47. This security traded at a volume of 566.4K shares come close, making up 202.2% of its average volume over the last 100 days. The market value of their outstanding shares is at $21.0 million.
180 Life Sciences (NASDAQ:ATNF) shares moved upwards by 8.65% to $0.65. The company's market cap stands at $3.8 million.
Matinas BioPharma Hldgs (AMEX:MTNB) stock moved upwards by 7.84% to $0.13. The company's market cap stands at $29.2 million.

TransCode Therapeutics (NASDAQ:RNAZ) stock declined by 20.0% to $2.04 during Monday's after-market session. This security traded at a volume of 15.7 million shares come close, making up 2625.3% of its average volume over the last 100 days. The market value of their outstanding shares is at $4.1 million.
Biophytis (NASDAQ:BPTS) stock fell 8.18% to $1.46. At the close, Biophytis's trading volume reached 6.6 million shares. This is 1490.8% of its average volume over the last 100 days. The company's market cap stands at $7.8 million.
NeuBase Therapeutics (NASDAQ:NBSE) stock decreased by 7.69% to $0.79. The market value of their outstanding shares is at $2.9 million.
Tivic Health Systems (NASDAQ:TIVC) stock fell 5.48% to $1.9. The company's market cap stands at $2.7 million.
Immix Biopharma (NASDAQ:IMMX) stock decreased by 5.44% to $2.8. The company's market cap stands at $45.5 million.
Inozyme Pharma (NASDAQ:INZY) shares decreased by 4.88% to $4.1. The company's market cap stands at $253.0 million. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Femasys (NASDAQ:FEMY) shares moved upwards by 56.8% to $0.52 during Monday's after-market session. This security traded at a volume of 461.0K shares come close, making up 12.7% of its average volume over the last 100 days. The company's market cap stands at $7.8 million.
Pliant Therapeutics (NASDAQ:PLRX) stock rose 15.85% to $16.89. The company's market cap stands at $1.0 billion.
Ontrak (NASDAQ:OTRK) stock moved upwards by 10.45% to $0.95. The company's market cap stands at $4.6 million.
Brainstorm Cell (NASDAQ:BCLI) stock moved upwards by 9.42% to $0.47. This security traded at a volume of 566.4K shares come close, making up 202.2% of its average volume over the last 100 days. The market value of their outstanding shares is at $21.0 million.
180 Life Sciences (NASDAQ:ATNF) shares moved upwards by 8.65% to $0.65. The company's market cap stands at $3.8 million.
Matinas BioPharma Hldgs (AMEX:MTNB) stock moved upwards by 7.84% to $0.13. The company's market cap stands at $29.2 million.

Femasys 纳斯达克股票代码：FEMY）股价在周一的盘后交易时段上涨56.8％，至0.52美元。该证券的交易量为46.10万股，占其过去100天平均交易量的12.7％。该公司的市值为780万美元。
Pliant Therape 纳斯达克股票代码：PLRX）股价上涨15.85％，至16.89美元。该公司的市值为10亿美元。
Ontrak 纳斯达克股票代码：OTRK）股价上涨10.45％，至0.95美元。该公司的市值为460万美元。
头脑风暴细胞 纳斯达克股票代码：BCLI）股价上涨9.42％，至0.47美元。该证券的交易量为56.64万股，占其过去100天平均交易量的202.2％。他们流通股的市值为2,100万美元。
180 生命科学 纳斯达克股票代码：ATNF）股价上涨8.65％，至0.65美元。该公司的市值为380万美元。
马蒂纳斯生物制药控股公司 (AMEX: MTNB) 股价上涨7.84％，至0.13美元。该公司的市值为2920万美元。

TransCode Therapeutics (NASDAQ:RNAZ) stock declined by 20.0% to $2.04 during Monday's after-market session. This security traded at a volume of 15.7 million shares come close, making up 2625.3% of its average volume over the last 100 days. The market value of their outstanding shares is at $4.1 million.
Biophytis (NASDAQ:BPTS) stock fell 8.18% to $1.46. At the close, Biophytis's trading volume reached 6.6 million shares. This is 1490.8% of its average volume over the last 100 days. The company's market cap stands at $7.8 million.
NeuBase Therapeutics (NASDAQ:NBSE) stock decreased by 7.69% to $0.79. The market value of their outstanding shares is at $2.9 million.
Tivic Health Systems (NASDAQ:TIVC) stock fell 5.48% to $1.9. The company's market cap stands at $2.7 million.
Immix Biopharma (NASDAQ:IMMX) stock decreased by 5.44% to $2.8. The company's market cap stands at $45.5 million.
Inozyme Pharma (NASDAQ:INZY) shares decreased by 4.88% to $4.1. The company's market cap stands at $253.0 million. See Also:

TransCode 治疗学 纳斯达克股票代码：RNAZ）股价在周一的盘后交易时段下跌20.0％，至2.04美元。该证券的交易量接近1,570万股，占其过去100天平均交易量的2625.3％。他们流通股的市值为410万美元。
生物植物 纳斯达克股票代码：BPTS）股价下跌8.18％，至1.46美元。收盘时，Biophytis的交易量达到660万股。这是其过去100天平均交易量的1490.8％。该公司的市值为780万美元。
NeuBase 疗法 纳斯达克股票代码：NBSE）股价下跌7.69％，至0.79美元。他们流通股的市值为290万美元。
Tivic 健康系统 纳斯达克股票代码：TIVC）股价下跌5.48％，至1.9美元。该公司的市值为270万美元。
Immix Biophar 纳斯达克股票代码：IMMX）股价下跌5.44％，至2.8美元。该公司的市值为4550万美元。
Inozyme 制药 纳斯达克股票代码：INZY）股价下跌4.88％，至4.1美元。该公司的市值为2.53亿美元。 另请参阅：

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文由Benzinga的自动内容引擎生成，并由编辑审阅。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。更多信息

风险及免责提示